TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations
2015 · Nature Communications · 138 citations
https://doi.org/10.1038/ncomms8951
S
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
2.3K
Citations
19
h-index
22
i10-index
Shuang Shang is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: RNA modifications and cancer & Immune Cell Function and Interaction & Epigenetics and DNA Methylation. The author has an h-index of 19, co-authored 33 publications.
ORCID: 0000-0002-8136-3043Papers by this author
worksTRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
2020 · Nature Communications · 57 citations
https://doi.org/10.1038/s41467-020-20107-1
ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer
2023 · Nature Communications · 54 citations
https://doi.org/10.1038/s41467-023-43548-w
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway
2023 · Science Translational Medicine · 33 citations
https://doi.org/10.1126/scitranslmed.ade4113
Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responses
2022 · Cancer Innovation · 22 citations
https://doi.org/10.1002/cai2.7
PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
2024 · Acta Pharmaceutica Sinica B · 10 citations
https://doi.org/10.1016/j.apsb.2024.08.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat